Oppenheimer Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price objective upped by investment analysts at Oppenheimer from $89.00 to $95.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price objective would suggest a potential upside of 7.60% from the company’s current price.

Several other analysts have also recently issued reports on the stock. Wells Fargo & Company upped their target price on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. The Goldman Sachs Group lifted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Deutsche Bank Aktiengesellschaft increased their price target on Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Berenberg Bank increased their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Finally, Jefferies Financial Group increased their price objective on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.19.

Corteva Price Performance

Shares of CTVA traded down $0.24 during midday trading on Thursday, hitting $88.29. 349,873 shares of the company traded hands, compared to its average volume of 3,936,359. The firm has a 50 day moving average of $81.13 and a 200-day moving average of $78.69. Corteva has a 52 week low of $60.53 and a 52 week high of $89.39. The stock has a market cap of $59.05 billion, a price-to-earnings ratio of 51.90, a PEG ratio of 2.64 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the previous year, the firm posted $1.13 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts forecast that Corteva will post 3.75 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Tema ETFs LLC boosted its stake in shares of Corteva by 10.4% during the second quarter. Tema ETFs LLC now owns 10,774 shares of the company’s stock valued at $912,000 after purchasing an additional 1,015 shares in the last quarter. City Holding Co. increased its holdings in shares of Corteva by 2.6% in the 2nd quarter. City Holding Co. now owns 25,086 shares of the company’s stock valued at $2,124,000 after acquiring an additional 635 shares during the period. Sax Wealth Advisors LLC purchased a new stake in shares of Corteva during the 2nd quarter worth $237,000. Avity Investment Management Inc. grew its stake in Corteva by 14.4% in the second quarter. Avity Investment Management Inc. now owns 5,172 shares of the company’s stock valued at $438,000 after purchasing an additional 650 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in shares of Corteva by 8.3% in the 2nd quarter. Valeo Financial Advisors LLC now owns 6,963 shares of the company’s stock valued at $589,000 after buying an additional 536 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.